Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (NXSCF)
:NXSCF
NXSCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.33
Previous CloseN/A
Volume6.25K
Average Volume (3M)1.41K
Market Cap
$18.39M
Enterprise Value$64.38M
Total Cash (Recent Filing)$7.48M
Total Debt (Recent Filing)$1.80M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Aug 27, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding292,160,250
10 Day Avg. Volume450
30 Day Avg. Volume1,406
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.67
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap3.50
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.97
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.25Price Target Upside400.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Next Science Ltd News
PremiumCompany Announcements
Next Science to Announce 1Q FY25 Results and Host Investor Webinar
PremiumCompany Announcements
Next Science Announces 2025 Annual General Meeting Details
PremiumCompany Announcements
Next Science Announces Change in Share Registry Provider
PremiumCompany Announcements
Next Science Schedules 2025 Annual General Meeting
PremiumCompany Announcements
TIGA Trading Increases Stake in Next Science
PremiumCompany Announcements
Thorney Technologies Increases Stake in Next Science
PremiumCompany Announcements
Next Science Ltd Reports FY24 Results, Expands Market Reach
PremiumCompany Announcements
Next Science Limited Reports Revenue and Profit Growth in FY24---
Options Prices
Currently, No data available
---
Ownership Overview
0.23% Insiders
<0.01% Other Institutional Investors
99.77% Public Companies and
Individual Investors
NXSCF FAQ
What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest stock price was $0.03 and its highest was $0.33 in the past 12 months.
What is Next Science Ltd’s market cap?
Next Science Ltd’s market cap is $18.39M.
When is Next Science Ltd’s upcoming earnings report date?
Next Science Ltd’s upcoming earnings report date is Aug 27, 2025 which is in 135 days.
How were Next Science Ltd’s earnings last quarter?
Next Science Ltd released its earnings results on Feb 27, 2025. The company reported -$0.015 earnings per share for the quarter, beating the consensus estimate of -$0.019 by $0.004.
Is Next Science Ltd overvalued?
According to Wall Street analysts Next Science Ltd’s price is currently Undervalued.
Does Next Science Ltd pay dividends?
Next Science Ltd does not currently pay dividends.
What is Next Science Ltd’s EPS estimate?
Next Science Ltd’s EPS estimate is -0.02.
How many shares outstanding does Next Science Ltd have?
Next Science Ltd has 292,160,250 shares outstanding.
What happened to Next Science Ltd’s price movement after its last earnings report?
Next Science Ltd reported an EPS of -$0.015 in its last earnings report, beating expectations of -$0.019. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Next Science Ltd?
Currently, no hedge funds are holding shares in NXSCF
---
Next Science Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.25 (400.00% Upside)
$0.25 (400.00% Upside)
Blogger Sentiment
Bullish
NXSCF Sentiment 70%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.27%
12-Months-Change
Fundamentals
Return on Equity
-130.18%
Trailing 12-Months
Asset Growth
-48.53%
Trailing 12-Months
Company Description
Next Science Ltd
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.
---
NXSCF Stock 12 Month Forecast
Average Price Target
$0.25
▲(400.00% Upside)
Technical Analysis
Best Analysts Covering NXSCF
1 Year
1 Year Success Rate
0/12 ratings generated profit
1 Year Average Return
-58.55%
reiterated a buy rating 3 months ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -58.55% per trade.
---